Tela Bio Stock Pattern Recognition Hikkake Pattern
| TELA Stock | USD 0.77 -0.003 -0.39% |
| Symbol |
Recognition |
The output start index for this execution was five with a total number of output elements of fifty-six. The function generated a total of two valid pattern recognition events for the selected time horizon. The Hikkake pattern is used for determining Tela Bio market turning-points and continuations.
Tela Bio Technical Analysis Modules
Most technical analysis of Tela Bio help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Tela from various momentum indicators to cycle indicators. When you analyze Tela charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
Tela Bio is scheduled to announce its earnings this week.TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patients anatomy. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. Tela Bio operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 123 people. This overview emphasizes how Tela Bio compares to peers on valuation quality and operating consistency. Current metrics include P/B of 22.31, profit margin of -50.61%. Tela Bio has a market cap of 34.38 M, ROE of -6.76%.
Methodology
Unless otherwise specified, financial data for Tela Bio is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Tela (USA Stocks:TELA) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The data underlying this report is sourced from public filings and market reference sources, including filings and releases published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Some updates may be delayed based on publication cadence. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Tela Bio may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Gabriel Shpitalnik - Member of Macroaxis Editorial BoardLearn to be your own money manager
Tracking Tela Bio inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
| All Next | Launch Module |
Tela Bio pair trading
Pair trading with Tela Bio can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Tela Bio Pair Trading
Tela Bio Pair Trading Analysis
The effectiveness of tax-loss harvesting on Tela Bio depends on finding a suitable replacement asset. Instruments with correlation above 0.9 to Tela Bio typically provide adequate market exposure during the required holding period.
Interpreting the correlation table for Tela Bio: readings above 0.8 indicate strongly correlated pairs with minimal diversification benefit, while readings between -0.2 and +0.2 around Tela Bio suggest near-independence and genuine portfolio diversification value.
Use Correlation analysis and pair trading evaluation for Tela Bio to review hedging context. The view can be extended across sectors or other related groups.More Resources for Tela Stock Analysis
A comprehensive view of Tela Bio starts with financial statements and ratio context. Key ratios help frame profitability, efficiency, and growth context for Tela Bio Stock. Key reports that frame Tela Bio Stock are listed below:Tela Bio has a market cap of 34.38 M, operating margin of -36.51%, ROE of -6.76%. Review World Market Map for broader portfolio context. This reflects a position in Tela Bio in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. Our How to Invest in Tela Bio guide provides practical guidance on trading Tela Stock.Analysis related to Tela Bio should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Earnings Share -0.83 | Revenue Per Share | Quarterly Revenue Growth 0.091 | Return On Assets | Return On Equity |
Understanding Tela Bio includes distinguishing between market value and book value, where book value reflects Tela's accounting equity. Tela Bio's market capitalization is 34.38 M. With a P/B ratio of 22.31, the market values Tela Bio well above its book equity. Enterprise value stands at 47.04 M. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
It is useful to distinguish Tela Bio's value from its trading price, which are computed with different methods. For Tela Bio, key inputs include a P/B ratio of 22.31, a profit margin of -50.61%, ROE of -6.76%, and revenue of 69.3 M. By contrast, market price reflects the level where buyers and sellers transact.